News
UB invest doctor honoris causa the oncologist and epidemiologist Francesc Xavier Bosch
The oncologist and epidemiologist Francesc Xavier Bosch has been awarded an honorary doctorate (Honoris Causa) by the University of Barcelona today February 11th, 2016. At the ceremony, which was held in the Paranimf, have acted as guarantors Francesc Cardellach, dean of the Faculty of Medicine, UB, and Victor Raul Moreno, professor of the Department of […]
DNA fingerprinting, a key for the survival of cancer patients who do not respond to standard treatments
Jaume Giró, General Manager of the “La Caixa” Bank Foundation, and Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Institute of Biomedical Research (IDIBELL), have presented today a pioneering study on epigenetic prediction of drug response to optimize cancer therapy in patients who no longer respond to standard treatments. The […]
ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities
The Direcció General de Recerca de la Secretaria d’Universitats i Recerca (Departament d’Empresa i Coneixement) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the optimization, adaptation, improvement of facilities and acquisition of technological equipment at IDIBELL because of the forthcoming integration of the Center for Regenerative Medicine in Barcelona (CMRB) in these spaces. […]
Brain plasticity in expert pianists depends on age of musical training onset
Cognition and Brain Plasticity Unit of Barcelona Cognition and Brain Plasticity Unit of Barcelona
C. elegans as a model to study cancer, in Genetics and Nature Medicine journals
Genetics Porta-de-la-Riva M, Cerón J, Nature Medicine.
Scientists identify new amino acid transporter in the kidney with potential impact on cystinuria
Research groups led by Dr. Virginia Nunes and Dr. Manuel Palacin, UB professors and researchers from Bellvitge Biomedical Research Institute (IDIBELL) and Institute for Research in Biomedicine Barcelona (IRB Barcelona), respectively, at the same time responsible for the Ciber 730 and U731 units for Rare Diseases (CIBERER), have identified the AGT1/rBAT protein as a new […]